Democratic Republic of the Congo starts the first-ever multi drug trial for an Ebola treatment. It is part of a multi-outbreak, multi-country study that was agreed to by partners under a WHO initiative.
Read moreEntebbe, 26th November 2018:- The Uganda Virus Research Institute (UVRI) has been certified to perform yellow fever regional reference lab functions in the Arbovirology department that supports yellow fever diagnostic su…
Read moreThe WHO Regional Director for Africa, Dr Matshidiso Moeti has urged African leaders to mobilize additional resources for the fight against malaria. She made this call during her two-day visit to Mozambique which wrapped up earlier this week.
Read moreThe Government of Nigeria – with support from the World Health Organization (WHO), Gavi, the Vaccine Alliance and UNICEF aims to vaccinate 26.2 million people this year through preventive campaigns. The second phase of its biggest-ever yellow fever campaign seeks to establish high population immunity nationwide and began today.
Read moreWHO and partners launch a new country-led response to put stalled malaria control efforts back on track.
Read more16 November 2018 – WHO has released details regarding membership of the Guidelines Development Group (GDG) for the 2019 “Consolidated guidelines on HIV testing services”. The meeting of the GDG will be held on 5…
Read moreQatar Fund for Development (QFFD) has signed an agreement with World Health Organization (WHO)’s Regional Office for Africa worth 3 million USD, on the sidelines of the World Innovation Summit for Health (WISH).
Read moreThe World Health Organization (WHO) welcomes the results from NAMSAL (New Antiretroviral and Monitoring Strategies in HIV-infected Adults in Low-income countries), a study conducted in Cameroon by the French Agency for Research on AIDS and Viral Hepatitis (ANRS). The study aims to compare the efficacy of two first-line treatments for HIV infection in more than 600 participants.
Read more